Myeloablative Autologous Transplantation of CD34 + Selected Hematopoietic Stem Cells (HSCT) vs Monthly Intravenous Cyclophosphamide (CY) for Severe Scleroderma with Internal Organ Involvement: Outcomes of a Randomized North American Clinical Trial Keith Sullivan, Lynettee Keyes-Elstein, Peter McSweeney, Ashley Pinckney, Beverly Welch, Maureen Mayes, Richard Nash, Leslie Crofford, Sharon Castina, Linda M. Griffith, Ellen Goldmuntz, Daniel Furst Biology of Blood and Marrow Transplantation Volume 23, Issue 3, Pages S23-S24 (March 2017) DOI: 10.1016/j.bbmt.2017.01.012 Copyright © 2016 Terms and Conditions
Figure 1 Global rank composite score. Biology of Blood and Marrow Transplantation 2017 23, S23-S24DOI: (10.1016/j.bbmt.2017.01.012) Copyright © 2016 Terms and Conditions
Figure 2 Kaplan-Meier estimates. Biology of Blood and Marrow Transplantation 2017 23, S23-S24DOI: (10.1016/j.bbmt.2017.01.012) Copyright © 2016 Terms and Conditions